ArticleFrontiers in pharmacology2026

Fuzheng Huayu tablets reduces the risk of further decompensation after the first decompensation in patients with HBV-related cirrhosis: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.

Lihua Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.